De novo mosaic MECP2 mutation in a female with Rett syndrome

We describe a female with Rett syndrome carrying a rare de novo mosaic nonsense mutation on MECP2 gene, with random X‐chromosome inactivation. Rett syndrome severity in females depends on mosaicism level and tissue specificity, X‐chromosome inactivation, epigenetics and environment. Rett syndrome should be considered in both males and females.

[1]  H. Warren,et al.  When Rett syndrome is due to genes other than MECP2 , 2018, Translational science of rare diseases.

[2]  K. Masuda,et al.  A rare male patient with classic Rett syndrome caused by MeCP2_e1 mutation , 2018, American journal of medical genetics. Part A.

[3]  N. Baena,et al.  The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome , 2017, Scientific Reports.

[4]  M. Fichera,et al.  MECP2 missense mutations outside the canonical MBD and TRD domains in males with intellectual disability , 2015, Journal of Human Genetics.

[5]  W. Kaufmann,et al.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome , 2015, American journal of medical genetics. Part A.

[6]  P. Riegman,et al.  Buccal swab as a reliable predictor for X inactivation ratio in inaccessible tissues , 2015, Journal of Medical Genetics.

[7]  B. Bradley,et al.  DNA extracted from saliva for methylation studies of psychiatric traits: Evidence tissue specificity and relatedness to brain , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  J. Christodoulou,et al.  MECP2-Related Disorders , 2012 .

[9]  S. Borrego,et al.  Somatic mosaicism for Y120X mutation in the MECP2 gene causes atypical Rett syndrome in a male , 2011, Brain and Development.

[10]  W. Kaufmann,et al.  Rett syndrome: Revised diagnostic criteria and nomenclature , 2010, Annals of neurology.

[11]  J. Armstrong,et al.  Novel FOXG1 mutations associated with the congenital variant of Rett syndrome , 2009, Journal of Medical Genetics.

[12]  L. Villard.  MECP2 mutations in males , 2007, Journal of Medical Genetics.

[13]  R. Hastings,et al.  Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype–phenotype associations in Rett syndrome , 2005, European Journal of Human Genetics.

[14]  J. Gécz,et al.  Early onset seizures and Rett-like features associated with mutations in CDKL5 , 2005, European Journal of Human Genetics.

[15]  Rodney C. Samaco,et al.  X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. , 2004, Human molecular genetics.

[16]  D. Cooper,et al.  Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. , 2000, Human molecular genetics.

[17]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[18]  D. Mabin.  Diagnostic criteria for Rett syndrome. The Rett Syndrome diagnostic criteria work group Ann. Neurol , 1988, Neurophysiologie Clinique/Clinical Neurophysiology.

[19]  Diagnostic criteria for rett syndrome , 1988 .

[20]  A Rett,et al.  [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. , 1966, Wiener medizinische Wochenschrift.

[21]  M. Topcu,et al.  Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy , 2002, European Journal of Human Genetics.

[22]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.